PT - JOURNAL ARTICLE AU - Akshay Jindal AU - Shrisha Rao TI - Lockdowns to Contain COVID-19 Increase Risk and Severity of Mosquito-Borne Disease Outbreaks AID - 10.1101/2020.04.11.20061143 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.11.20061143 4099 - http://medrxiv.org/content/early/2020/04/17/2020.04.11.20061143.short 4100 - http://medrxiv.org/content/early/2020/04/17/2020.04.11.20061143.full AB - Many countries are implementing lockdown measures to slow the COVID-19 pandemic, putting more than a third of the world’s population under restrictions. The scale of such lockdowns is unprecedented, and while some effects of lockdowns are readily apparent, it is less clear what effects they may have on outbreaks of serious communicable diseases. We examine the impact of these lockdowns on outbreaks of mosquito-borne diseases. Using an agent-based model and simulations, we find that the risk and severity of such outbreaks is much greater under lockdown conditions, with the number of infected people doubling in some cases. This increase in number of cases varies by different mosquito-borne diseases, and is significantly higher for diseases spread by day-biting mosquitoes. We analysed various intervention strategies and found that during lockdowns, decentralised strategies such as insecticide-treated nets and indoor residual spraying are more effective than centralised strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of the second author was supported in part by an AWS Machine Learning Research Award from Amazon.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data required are available as noted in the paper. https://github.com/akshayjin/chikungunya_simulation